A multicenter, randomized, parallel-controlled, exploratory trial for anlotinib hydrochloride versus cisplatin plus docetaxel in the treatment of non-T790M mutated advanced non-small cell lung cancer
Latest Information Update: 10 Jul 2019
At a glance
- Drugs Catequentinib (Primary) ; Cisplatin; Docetaxel
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
Most Recent Events
- 10 Jul 2019 New trial record